Today, UCB issued the following statement from Jeffrey Stark, M.D., Head of U.S. Medical Immunology, on the recent update by the ICD-10 Coordination and Maintenance Committee to endorse the creation of a new sub-category (M45.A) for non-radiographic axial spondyloarthritis (nr-axSpA). 

UCB is passionate about transforming the lives of people living with severe diseases and uncovering the intersections of scientific understanding and patient needs. This May, we are honoring Arthritis Awareness Month and Spondyloarthritis Awareness Month by exploring the impacts of different kinds of arthritis on patients. Learn more about psoriatic arthritis, rheumatoid arthritis, and non-radiographic axial spondyloarthritis, their prevalence, and how individuals living with these diseases are impacted.

As we join the rheumatology community at ACR Convergence 2020, Head of U.S. Medical Immunology, Dr. Jeff Stark, shares the importance of a new diagnostic code for nr-axSpA in helping to improve the patient journey and to lead to more innovation. Read more.

Learn more about living with non-radiographic axial spondyloarthritis (nr-axSpA) from Chelsea, who recently shared her story.